3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
As new pharmaceutical drugs enter the market, they may secure a financially promising disease indication, especially if there are no available treatment options. Their specific formulation, manufacturing standards and proven …
Read More